Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA-STAR Awards $354,826 for CMT Clinical Trial
…consolidated under the banner of STAR—which brings together the world’s largest network of biotech research partners, research scientists, clinicians and patients—and funds more CMT grants than any other philanthropic organization…
Type 1 CMT Gene Therapy Project Now Underway
…Accelerate Research (STAR) brings top researchers together with pharmaceutical and biotechnology partners to accelerate scientific breakthroughs. STAR has one goal: to accelerate the development of treatments for CMT. Both research…
MDA and CMTA Partner to Advance Treatments and Care for Charcot-Marie-Tooth Disease
…the field and increasing collaboration among research and clinical investigators. With the launch of this partnership, MDA and CMTA plan to co-fund research and training grants, collaborate on infrastructure initiatives,…
STAR Advisory Board
…soundness of the research strategy. The progress of research teams, recommending changes in research strategies as needed. The Therapy Expert Board (TEB) evaluates the translational quality of ongoing and proposed…
Development of Treatments for CMT2D
…support the CMTA’s research efforts and enable expanded partnerships with world leading research laboratories, please consider making a donation in support of the CMTA’s Strategy to Accelerate Research. Published: June…
Help CMTA Develop Clinical Trials in a Dish
…they can become cells with specialized functions. Stem cells collected from CMT patients are an important tool for CMT research. They can be turned into neurons and glia, cell types…
Understanding Charcot-Marie-Tooth Disease in Children
This CMT awareness month, the CMTA’s Chief Research Officer, Katherine Forsey, PhD, shares her perspective as a CMT mum and how she navigated her own child’s participation in CMT research….
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
…their work. The CMTA has invested $23.5 million in its Strategy to Accelerate Research (STAR) since it was implemented in 2008, making it the world’s largest funder of CMT research….
CMTA Appoints David Skarinsky to its Therapy Expert Board
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research that’s aimed at bringing treatments and a cure to patients of this rare disease, is pleased to…
Project Foresee: The Path to Cure CMT4C
…cure the first handful of patients in the next 3 years. Brief History of CMT4C Gene Therapy research and promising results: Initial CMTA backed research on a CMT4C Gene Therapy…